Activity from announced rounds
LG Technology Ventures is the corporate venture organization identified in its own Spectro Cloud release and RegCell’s investor announcement.
Spectro manages cloud infrastructure. RegCell reprograms immune cells for cell therapies, while Zenity secures enterprise agents. The venture organization retains its identity separately from the LG parent and other named units.
RegCell is developing cell therapies for autoimmune disease by epigenetically reprogramming pathogenic conventional T cells into stable regulatory T cells, aiming to restore immune tolerance without gene engineering; its platform is advancing toward clinical development.